Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis.
Saved in:
| Title: | Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis. |
|---|---|
| Authors: | Lachiewicz AM; Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA., Shah M; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., Der T; Duke University School of Medicine, Durham, NC, USA., Cyr D; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., Al-Khalidi HR; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., Lindsell C; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA., Iyer V; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota., Khan A; Division of Pulmonary, Allergy and Critical Care Medicine, Oregon Health & Science University, Portland, OR, USA., Panettieri R; Rutgers Institute for Translational Medicine and Science, New Brunswick, NJ, USA., Rauseo AM; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Maillo M; Sanatorio Diagnóstico S.A., Santa Fe, Argentina., Schmid A; Division of Pulmonary Disease, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Jagpal S; Division of Pulmonary Disease and Critical Care Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Powderly WG; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Bozzette SA; National Center for Advancing Translational Sciences, Bethesda, MD, USA. |
| Corporate Authors: | ACTIV-1 IM study group members |
| Source: | CHEST critical care [CHEST Crit Care] 2024 Dec; Vol. 2 (4). Date of Electronic Publication: 2024 Aug 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918681585806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2949-7884 (Electronic) Linking ISSN: 29497884 NLM ISO Abbreviation: CHEST Crit Care Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39610848 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lachiewicz+AM%22">Lachiewicz AM</searchLink>; Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Shah+M%22">Shah M</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Der+T%22">Der T</searchLink>; Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Cyr+D%22">Cyr D</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Al-Khalidi+HR%22">Al-Khalidi HR</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lindsell+C%22">Lindsell C</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+V%22">Iyer V</searchLink>; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Khan+A%22">Khan A</searchLink>; Division of Pulmonary, Allergy and Critical Care Medicine, Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Panettieri+R%22">Panettieri R</searchLink>; Rutgers Institute for Translational Medicine and Science, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Rauseo+AM%22">Rauseo AM</searchLink>; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Maillo+M%22">Maillo M</searchLink>; Sanatorio Diagnóstico S.A., Santa Fe, Argentina.<br /><searchLink fieldCode="AU" term="%22Schmid+A%22">Schmid A</searchLink>; Division of Pulmonary Disease, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Jagpal+S%22">Jagpal S</searchLink>; Division of Pulmonary Disease and Critical Care Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Powderly+WG%22">Powderly WG</searchLink>; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Bozzette+SA%22">Bozzette SA</searchLink>; National Center for Advancing Translational Sciences, Bethesda, MD, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22ACTIV-1+IM+study+group+members%22">ACTIV-1 IM study group members</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918681585806676%22">CHEST critical care</searchLink> [CHEST Crit Care] 2024 Dec; Vol. 2 (4). <i>Date of Electronic Publication: </i>2024 Aug 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+Inc%22">Elsevier, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918681585806676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2949-7884 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229497884%22">29497884 </searchLink><i>NLM ISO Abbreviation: </i>CHEST Crit Care <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39610848 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.chstcc.2024.100095 Languages: – Code: eng Text: English Titles: – TitleFull: Resource Use in the Randomized Master Protocol for Immune Modulators for Treating COVID-19 (ACTIV-1 IM): A Secondary Data Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lachiewicz AM – PersonEntity: Name: NameFull: Shah M – PersonEntity: Name: NameFull: Der T – PersonEntity: Name: NameFull: Cyr D – PersonEntity: Name: NameFull: Al-Khalidi HR – PersonEntity: Name: NameFull: Lindsell C – PersonEntity: Name: NameFull: Iyer V – PersonEntity: Name: NameFull: Khan A – PersonEntity: Name: NameFull: Panettieri R – PersonEntity: Name: NameFull: Rauseo AM – PersonEntity: Name: NameFull: Maillo M – PersonEntity: Name: NameFull: Schmid A – PersonEntity: Name: NameFull: Jagpal S – PersonEntity: Name: NameFull: Powderly WG – PersonEntity: Name: NameFull: Bozzette SA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2024 Dec Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2949-7884 Numbering: – Type: volume Value: 2 – Type: issue Value: 4 Titles: – TitleFull: CHEST critical care Type: main |
| ResultId | 1 |